Financial Fitness Check: Examining Cogent Biosciences Inc (COGT)’s Key Ratios

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

In the latest session, Cogent Biosciences Inc (NASDAQ: COGT) closed at $8.80 up 5.01% from its previous closing price of $8.38. In other words, the price has increased by $5.01 from its previous closing price. On the day, 2.85 million shares were traded. COGT stock price reached its highest trading level at $9.02 during the session, while it also had its lowest trading level at $8.16.


For a deeper understanding of Cogent Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.05 and its Current Ratio is at 12.05. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on February 26, 2024, Downgraded its rating to Neutral and sets its target price to $8 from $14 previously.

On February 08, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $11.

Wedbush Downgraded its Outperform to Neutral on December 11, 2023, while the target price for the stock was maintained at $5.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 09 ’23 when Fairmount Funds Management LLC bought 800,000 shares for $12.00 per share. The transaction valued at 9,600,000 led to the insider holds 3,272,124 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, COGT now has a Market Capitalization of 841397952 and an Enterprise Value of 646333888.

Stock Price History:

Over the past 52 weeks, COGT has reached a high of $13.50, while it has fallen to a 52-week low of $3.67. The 50-Day Moving Average of the stock is 24.27%, while the 200-Day Moving Average is calculated to be 14.45%.

Shares Statistics:

For the past three months, COGT has traded an average of 1.40M shares per day and 1484500 over the past ten days. A total of 86.12M shares are outstanding, with a floating share count of 76.11M. Insiders hold about 20.40% of the company’s shares, while institutions hold 95.58% stake in the company. Shares short for COGT as of 1715731200 were 13460722 with a Short Ratio of 9.58, compared to 1713139200 on 12470238. Therefore, it implies a Short% of Shares Outstanding of 13460722 and a Short% of Float of 15.840000000000002.

Most Popular